Ferring Announces Recipients of Innovation Grants Program 2017-2018
in Uncategorized on
Ferring Pharmaceuticals today announced the recipients of the 2017-2018 Innovation Grants Program, an annual initiative of the Ferring Research Institute…
0
-
Read more
-
Ferring enters into worldwide OmniAb® platform license agreement with Ligand
in Uncategorized onRead moreFerring Pharmaceuticals announced today that it has entered into a worldwide license agreement with Ligand Pharmaceuticals to use…
-
Global agreement with FKD to commercialise novel gene therapy for bladder cancer patients
in TIMELINES onRead moreLorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
-
Acquisition of Rebiotix Inc. Microbiota Restoration Therapy
in TIMELINES onRead moreLorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
-
Ferring and the Chinese Academy of Sciences collaborate to advance research in reproductive medicine
in Uncategorized onRead moreFerring Pharmaceuticals and the Chinese Academy of Sciences (CAS) today announced a long-term collaboration to advance basic…
-
Launch of Testavan® (testosterone)
in TIMELINES onRead moreLorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.